|
Rare Glycogen Storage Diseases Natural History Study
RECRUITINGSponsored by Duke University
Actively Recruiting
SponsorDuke University
Started2024-12-23
Est. completion2034-12
Eligibility
Age0 Years – 90 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06795152
Summary
The purpose of this study is to collect and study key medical data about several ultra-rare GSDs (Glycogen Storage Diseases) including, but not limited to, GSD types 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome and Danon disease.
Eligibility
Age: 0 Years – 90 YearsHealthy volunteers accepted
Inclusion Criteria: * Diagnosis of a rare GSD, including 0a, 0b, VII, X, XII, XIII, XV, PRKAG2 syndrome or Danon disease * Two variants in the gene associated with the specific GSD type (for autosomal recessive diseases) * One variant in the gene associated with the specific GSD type (for autosomal dominant or X-linked diseases) * Deficient enzyme activity in liver, muscle, skin fibroblast or other tissue * One variant in causative gene with evidence of disease, per a clinician * Histology as confirmed by a clinician * Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative) * Able to provide consent for release of medical records * Pregnant women with a diagnosis of a rare GSD will be included Exclusion Criteria: * Unable to provide informed consent for participation for one's self or by legally authorized representative/legal guardian/parent
Conditions16
Danon DiseaseGSD Type 0AGSD Type 0BGSD VIIGSD XGSD XIIGSD XIIIGSD XVGlycogen Storage DiseaseHeart Disease
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorDuke University
Started2024-12-23
Est. completion2034-12
Eligibility
Age0 Years – 90 Years
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →
NCT06795152